Brewin Dolphin LTD Tekla Life Sciences Investors Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 09, 2023	SELL	$20.27 - $22.67 $54,323 - $60,755	-2,680 Closed	0 $0
Q4 2018 Nov 09, 2023	BUY	$13.99 - $20.35 $6,015 - $8,750	430 Added 19.11%	2,680 $40.5 Million
Q2 2018 Nov 09, 2023	BUY	$18.13 - $19.4 $24,294 - $25,995	1,340 Added 147.25%	2,250 $42.3 Million
Q4 2017 Nov 09, 2023	BUY	$18.31 - $22.24 $6,408 - $7,783	350 Added 62.5%	910 $17.9 Million
Q3 2017 Nov 09, 2023	BUY	$20.12 - $21.88 $11,267 - $12,252	560	560 $12 Million

Others Institutions Holding HQL

# of Institutions

77

Shares Held

9.31M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$46.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.5 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.61 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.33 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.63 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.